BRIEF-Biohaven Announces Robust Clinical Data With Single Dose Rimegepant That Defines Acute And Durable Benefits To Patients
April 22 Biohaven Pharmaceutical Holding Company Ltd:
* Says it will take over welfare facilities lending and sales business from WELLFAR Corporation for 30 million yen, effective June 1
* WUXI APPTEC SAYS IT AIMS TO RAISE UP TO 2.25 BILLION YUAN ($357.45 million) IN INITIAL SHANGHAI SHARE OFFERING AT 21.6 YUAN PER SHARE Source text in Chinese: https://bit.ly/2qWhzES Further company coverage: ($1 = 6.2945 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)
April 23Body Organ Biomedical Corp * Says it will pay no dividend to shareholders for 2017 Source text in Chinese:https://goo.gl/GxF28H Further company coverage: (Beijing Headline News)
LONDON, April 23 (Thomson Reuters Foundation) - Like many combat veterans, Steve Hammond struggled for years after returning to civilian life, battling physical injuries that made it difficult to find a job and left him contemplating suicide.
No related earnings announcements are currently scheduled within the next 7 days.